Repeated Cisplatin Treatments inhibit Gastrointestinal Motility and Induces Baroreflex Changes and Mechanical Hyperalgesia in Rats

REFERENCES

• Rosenberg B, Van camp L, Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from platinum electrodes. Nature 1965;205:698–699.
   PubMed Web of Science ®Google Scholar
• O'Dwyer PJ, Stevenson JP, Johnson SW. Clinical pharmacokinetics and administration of established platinum drugs. Drugs 2000;59(4):19–27.
   PubMedGoogle Scholar
• Decatris MP, Sundar S, O'Byrne KJ. Platinum-based chemotherapy in metastatic breast cancer: current status. Cancer Treat Rev 2004;30(1):53–81.
   PubMed Web of Science ®Google Scholar
• Timmer-Bosscha H, Mulder NH, Vries EG. Modulation of cis-diamminedichloroplatinum (II) resistance: a review. Br J Cancer 1992;66(2):227–238.
   PubMed Web of Science ®Google Scholar
• Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003;22(47):7265–7279.
   PubMed Web of Science ®Google Scholar
• Cornelison TL, Reed E. Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin. Gynecol Oncol 1993;50(2):147–158.
   PubMed Web of Science ®Google Scholar
• Pabla N, Kidney ZD. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Inte 2008;73:994–1007.
   Google Scholar
• Cano JR, Catalán B, Jará C. Neuronopathy due to cisplatin. Ver Neurol 1998;27(158):606–610.
   Google Scholar
• Smoorenburg GF, De Groot JC, Hamers FP, Klis SF. Protection and spontaneous recovery from cisplatin-induced hearing loss. Ann N Y Acad Sci 1999;884:192–210.
   Google Scholar
• Glendenning JL, Barbachano Y, Norman AR, Dearnaley DP, Horwich A, Huddart RA. Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular. Cancer 2010;116(10):2322–2331.
   PubMed Web of Science ®Google Scholar
• Schilder RJ, LaCreta FP, Perez RP, Johnson SW, Brennan JM, Rogatko A, Nash S, McAleer C, Hamilton TC, Roby D, Young RC, Ozols RF, O'Dwyer PJ. Phase I and pharmacokinetic study of Ormaplatin (Tetraplatin, NSC 363812). Cancer Res 1994;54:709–717.
   PubMed Web of Science ®Google Scholar
• Pisano C, Pratesi G, Laccabue D, Zunino F, Lo Giudice P, Bellucci A, Pacifici L, Camerini B, Vesci L, Castorina M, Cicuzza S, Tredici G, Marmiroli P, Nicolini G, Galbiati S, Calvani M, Carminati P, Cavaletti G. Paclitaxel and cisplatin-induced neurotoxicity: a protective role of Acetyl-L-Carnitine. Clin Cancer Res 2003;9:5756–5767.
   PubMed Web of Science ®Google Scholar
• Alaedini A, Xiang Z, Kim H, Sung YJ, Latov N. Up-regulation of apoptosis and regeneration genes in the dorsal root ganglia during cisplatin treatment. Exp Neurol 2008;210(2):368–374.
   PubMed Web of Science ®Google Scholar
• Krarup-Hansen A, Rietz B, Krarup C, Heydorn K, Rorth M, Schmalbruch H. Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study. Neuropathol Appl Neurobiol 1999;25(1):29–40.
   PubMed Web of Science ®Google Scholar
• Earl HM, Connolly S, Latoufis C, Eagle K, Ash CM, Fowler C, Souhami RL. Long-term neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomas. Sarcoma 1998;2:97–105.
   PubMedGoogle Scholar
• Cabezos PA, Vera G, Castillo M, Fernández-Pujol R, Martín MI, Abalo R. Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with pica. Auton Neurosci 2008;141(1–2):54–65.
   PubMed Web of Science ®Google Scholar
• Cabezos PA, Vera G, Martin-Fontelles MI, Fernandez-Pujol R, Abalo R. Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat: comparison with pica. Neurogastroenterol Motil 2010;22(7):797–805.
   PubMedGoogle Scholar
• Bradner WT, Schurig JE. Toxicology screening in small animals. Cancer Treat Rev 1981;8(2):93–102.
   PubMed Web of Science ®Google Scholar
• Reynell PC, Spray GH. The simultaneous measurement of absorption and transit in the gastro-intestinal tract of the rat. J Physiol 1956;131:452–462.
   PubMedGoogle Scholar
• Gondim FA, Rodrigues CL, Da Graça JR, de Alencar HM, dos Santos AA, Rola FH. Neural mechanisms involved in the delay of gastric emptying and gastrointestinal transit of liquid after thoracic spinal cord transection in awake rats. Auton Neurosci 2001;87(1):52–58.
   PubMed Web of Science ®Google Scholar
• Gondim FA, Rodrigues CL, Lopes, AC, Jr., Camurça FL, Freire CC, Dos Santos AA, Rola FH. Effect of preinjury large bowel emptying on the inhibition of upper gastrointestinal motility after spinal cord injury in rats. Dig Dis Sci 2003;48(9):713–1718.
   PubMedGoogle Scholar
• Eddy NB, Leimbach D. Synthetic analgesics: II Dithienylbutenyl and dithienylbutylamines. J. Pharmacol. Exp Ther 1953;107:385–393.
   PubMed Web of Science ®Google Scholar
• O'Callaghan JP, Holtzman SG. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. J Pharmacol Exp Ther 1975;192:497–505.
   PubMed Web of Science ®Google Scholar
• El Maarouf A, Kolesnikov Y, Pasternak G, Rutishauser U. Polysialic acid-induced plasticity reduces neuropathic insult to the central nervous system. Proc Natl Acad Sci USA 2005;102(32):11516–11520.
   PubMed Web of Science ®Google Scholar
• Gondim FA, Oliveira GR, Graça JR, Gondim RB, Alencar HM, Dantas RP, Rola FH. Neural mechanisms involved in the delay of gastric emptying of liquid elicited by acute blood volume expansion in awake rats. Neurogastroenterol Motil 1999;11:93–99.
   PubMed Web of Science ®Google Scholar
• Cardoso LM, Pedrosa ML, Silva ME, Moraes MF, Colombari E, Chianca da J.R. Baroreflex function in conscious rats submitted to iron overload. Braz J Med Biol Res 2005;38(2):205–214.
   PubMed Web of Science ®Google Scholar
• Nelson K, Walsh D, Sheehan F. Cancer and chemotherapy-related upper gastrointestinal symptoms: the role of abnormal gastric motor function and its evaluation in cancer patients. Support Care Cancer 2002;10:455–461.
   PubMed Web of Science ®Google Scholar
• Robinson R, Cantwell BMJ. Autonomic neuropathy after cisplatin based chemotherapy. Br Med J 1990;300:466–475.
   Google Scholar
• Kishibayashi N, Ichikawa S, Yokoyama T, Ishii A, Karasawa A. Pharmacological properties of KF 18259, a novel 5-HT3-receptor antagonist, in rats: inhibition of the distal colonic function. Jpn J Pharmacol 1993;63(4):495–502.
   PubMedGoogle Scholar
• Osama A, Badary OA, Awad AS, Sherief MA, Hamada FMA. In vitro and in vivo effects of ferulic acid on gastrointestinal motility: inhibition of cisplatin-induced delay in gastric emptying in rats. World J Gastroenterol 2006;12(33):5363–5367.
   PubMed Web of Science ®Google Scholar
• De Jonghe BC, Horn CC. Chemotherapy agent cisplatin induces 48-hr Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus). Am J Physiol Regul Integr Comp Physiol 2009;296, R902–R911.
   PubMed Web of Science ®Google Scholar
• Boogerd W, Ten Bokkel Huinink WW, Dalesio O, Hoppenbrouwers WJ, Van der Sande JJ. Cisplatin induced neuropathy: central, peripheral and autonomic nerve involvement. J Neurooncol 1990;9(3):255–263.
   PubMed Web of Science ®Google Scholar
• Ta LE, Espeset L, Podratz J, Windebank AJ. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 2006;27(6):992–1002.
   PubMed Web of Science ®Google Scholar
• Authier N., Fialip J, Eschalier A, Coudoré F. Assessment of allodynia and hyperalgesia after cisplatin administration to rats. Neurosci Lett 2000;291(2):73–76.
   PubMed Web of Science ®Google Scholar
• Authier N, Gillet JP, Fialip J, Eschalier A, Coudore F. An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections. Exp Neurol 2003;182(1): 12–20.
   PubMed Web of Science ®Google Scholar
• Boyle FM, Wheeler HR, Shenfield GM. Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate. J Neurooncol 1999;41(2):107–116.
   PubMed Web of Science ®Google Scholar